signalgroup

Get more out of your business.

Reach it with Microsoft Dynamics 365 Business Central.

February 4, 2020 signalgroup

President Trump Can Look to Biosimilars to Keep Promise of Saving Americans Billions in Health Care Costs

February 3, 2020 signalgroup

Biosimilars Forum Praises FTC and FDA Action to Fight Anticompetitive Behaviors Blocking Access to Lower Cost Biosimilars

December 12, 2019 signalgroup

Biosimilars Forum Statement on Policies Supporting Biosimilar Uptake in Canadian Market

December 12, 2019 signalgroup

Biosimilars Forum Congratulates Dr. Stephen Hahn on Confirmation to Lead the Food and Drug Administration (FDA)

November 25, 2019 signalgroup

ICYMI: Biosimilars are a Recognized, Bipartisan Solution to Lowering Health Care Costs; Nominee for FDA Commissioner Reinforces Need to Increase Access for Biosimilars

November 20, 2019 signalgroup

Biosimilars Forum Statement Regarding Nomination of Dr. Stephen Hahn as Next Commissioner of the Food and Drug Administration (FDA)

November 13, 2019 signalgroup

The Biosimilars Forum Reacts to CMS Report on Increased Medicare Premiums for Seniors

November 11, 2019 signalgroup

ICYMI: Trump Administration’s Joe Grogan Recognizes Need for Biosimilar Incentives to Help Lower Healthcare Costs

October 18, 2019 signalgroup

The Biosimilars Forum Applauds Launch of New FDA Performance Dashboard

October 9, 2019 signalgroup

The Biosimilars Forum Applauds Congressmen Paul Tonko (D-NY) and Bob Gibbs (R-OH) for Introducing Legislation Mandating a CMS Star Ratings Program for Biosimilars